1[1]Ian Zachary.Molecules in focus vascular endothelial growth factor.The International Journal of Biochemistry & Cell Biology,1998,30:1169-1174.
2[2]Maxwell PH.Activation of the HIF pathway in cancer.Curr Opin Genet Dev,2001,11:293-299.
3[3]Christitane BH,Edurne B,Jacques P.Hypoxia:the tumor's gateway to progression along the angiogenic pathway.Trends in Cell Biology,2001,11:32-36.
4[4]Teraoka H,Nishihara T,Ohira M,et al.Enhanced VEGF production decreased immunogenicity induced by TGF-β1 promote liver metastasis of pancreatic cancer.Br J Cancer,2001,85:612-617.
5[5]Ravi R,Mookergee B,Bhujwalla Z,et al.Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1α.Genes Dev,2000,14:34-44.
6[6]Soumitro P,Kaustubh D,Dababrata M.Central role of P53 on regulation of vascular permeability factor/vascular endothelial factor(VPF/VEGF)expression in mammary crcinoma.Cancer Research,2001,61:6952-6956.
7[7]Ikeda N,Adachi M,Taki T,et al.Prognostic significance of angiogenesis in human pancreatic cancer.Br J Cancer.1999,79:1553-1563.
8[8]Fujimoto J,Sakaguchi R,Hirose R,et al.Expression of vascular endothelial growth factor(VEGF)and its mRNA in uterine cancers.Br J Cancer,1999,80:827-833.
9[9]Torahiko J,Michael L,Calyman DDS.Antisense inhibition of vascular endothelial growth factor in human head and neck squamous cell carcinoma.Head ＆ Neck,2000,8:483-487.
10[10]Rapisarda A,Uranchimeg B,Scudiero DA,et al.Identification of small molecule inhibitors of bypoxia-inducible factor 1 transcriptional activation pathway.Cancer Res,2002,62:4316-4324.
